Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Nakao, A.
Right arrow Articles by Tanaka, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakao, A.
Right arrow Articles by Tanaka, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 31:157-161 (2001)
© 2001 Foundation for Promotion of Cancer Research

A Family of Multiple Endocrine Neoplasia Type 2A with the RET Proto-oncogene Mutation in Codon 618 (Cys->Arg)

Atsunori Nakao1, Yoshio Naomoto1, Masafumi Kataoka1, Minoru Haisa1, Kazuhiko Kataoka1, Shinya Saitoh1, Toshiyoshi Fujiwara1, Tomoki Yamatsuji1, Kaoru Shigemitsu1, Tatsuo Umeoka1, Hiroshi Isozaki1, Hitoyasu Futami2, Ken Yamaguchi2 and Noriaki Tanaka1,+,§

1First Department of Surgery, Okayama University School of Medicine, Okayama and 2Growth Factor Division, National Cancer Center Research Institute, Tokyo, Japan

Multiple endocrine neoplasia type 2 (MEN-2) is a hereditary syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytoma and hyperplasia or adenoma of the parathyroid gland with hyperparathyroidism. Recent genetic studies have identified the presence of germline missense mutations in the RET proto-oncogene in almost 100% of MEN-2 patients. We report here three generations of one MEN-2 family with rare missense mutation at codon 618 (Cys->Arg) of the RET proto-oncogene. The first patient was surgically treated at the age of 63 years but died of bone metastasis. His two children (29-year-old daughter and 25-year-old son) were treated surgically for MTC and neck lymph node metastasis. Germline mutations of the RET proto-oncogene of these three MTC patients and two children of the 29-year-old daughter (9-year-old female and 7-year-old male) were examined. Three MTC patients and the 9-year-old female possessed the mutation. The phenotype of the family with this rare point mutation of the RET proto-oncogene is reported.

+ For reprints and all correspondence: Masafumi Kataoka, First Department of Surgery, Okayama Medical School, 2–5–1 Shikata-Cho, Okayama, Okayama 700-8558, Japan. E-mail: mkataoka@med.okayama-u.ac.jp

§ Abbreviations: MEN-2, multiple endocrine neoplasia type 2; MTC, medullary thyroid carcinoma; FMTC, familial medullary thyroid carcinoma; CT, computed tomography; MIBG, m-iodobenzylguanidine; PCR–SSCP, polymerase chain reaction–single strand conformation polymorphism


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.